Comparing two eye-imaging devices for eye tumors
Part of Cancer, Eyes & vision clinical trials.
This study compares two non-invasive imaging machines (OCT) that take detailed pictures of eye tumors. The goal is to see which machine gives better images, helping doctors choose the best tool for diagnosing and monitoring eye tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have a tumor in or on the surface of at least one eye.
- Your pupil in the study eye can be widened (dilated) to at least 3 mm.
- Your eye lens is natural or an artificial lens, and not cloudy enough to block the view inside.
- You can focus your gaze on a target and sit still for about 2 minutes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
This study evaluates a new retinal imaging device (Intalight Dream OCTA) by comparing its images with standard eye imaging methods. If you have a retinal condition that requires imaging tests, this trial helps doctors understand how well the new technology works.
This study tests whether patients can use a portable eye-imaging device (OCT, which takes detailed pictures of the eye) at home to monitor their own eye health. The goal is to see if self-monitoring helps patients track changes and work better with their eye doctors.
This trial compares two different imaging systems (Clarus and Optos) to see how well they can capture images of the retina in people with inherited retinal diseases. The goal is to find which system works better for diagnosing and tracking these conditions.
This trial tests two different devices that measure your eyes before cataract surgery to see which one helps doctors choose the best lens implant. The goal is to get your vision as close to perfect as possible after surgery.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
Hear when a new Ocular Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.